Eli Lilly reported dysesthesia was "generally mild" and "rarely led to discontinuation." TRIUMPH-1 the larger general obesity trial with 2,339 patients at 80 weeks confirmed dysesthesia at 12.5% on the 12mg dose, substantially lower than TRIUMPH-4's 20.9%
Curr Med Res Opin 24(10): 29432952 34
The question worth asking isn't whether one is better than the other in absolute terms it's whether they're actually doing the same job, and which one is right for the person reading this
European Journal of Applied Physiology, 99(2), 193199
Perhaps most telling is the comparison with GLP-1 receptor agonists as a class
Side Effects of L-Carnitine Some potential side effects include nausea, vomiting, upset stomach, and diarrhea